brain natriuretic peptide

DRUG3 trials

Sponsors

Mayo Clinic, Vanderbilt University, Royal Brompton & Harefield NHS Foundation Trust

Conditions

Aortic StenosisDiabetes Type 2HypertensionHypertension Stage 1

Phase 1

B-type Natriuretic Peptide (BNP) in Human Hypertension

TerminatedNCT00953472

Mayo ClinicHypertension Stage 1

Start: 2009-02-28End: 2011-04-30Target: 8Updated: 2011-10-12

Unknown Phase

Pharmacogenetics of Ace Inhibitor-Associated Angioedema

CompletedNCT01413542

Vanderbilt UniversityDiabetes Type 2, Hypertension

Start: 2011-11-30End: 2014-07-31Updated: 2015-11-04

A Comparison of Advanced Imaging Techniques in Aortic Stenosis

WithdrawnNCT01775215

Royal Brompton & Harefield NHS Foundation TrustAortic Stenosis

Start: 2013-01-31End: 2016-01-31Updated: 2014-12-02

Related Papers

Dipeptidyl‐Peptidase 4 Inhibition and the Vascular Effects of Glucagon‐like Peptide‐1 and Brain Natriuretic Peptide in the Human Forearm

Journal of the American Heart Association2014-08-1538 citations

Substance P Increases Sympathetic Activity During Combined Angiotensin-Converting Enzyme and Dipeptidyl Peptidase-4 Inhibition

Hypertension2014-02-1165 citations